Find uplifting stories about heroes, innovations, and solutions
6727 results for "cognitive treatment"
Scientists at Northwestern University discovered a biomarker that could lead to the first effective treatment for cognitive symptoms of schizophrenia, potentially helping millions live independently. A single injection improved brain function in early tests with no negative side effects.
A new drug called EG501 significantly improved cognitive function in lupus patients during a 12-week trial, offering hope for the 80% who struggle with debilitating brain fog. Vanderbilt researchers discovered the biological cause and successfully targeted it with treatment.
Starting HIV treatment immediately after diagnosis can prevent irreversible brain damage, giving 1.75 million older South Africans living with the virus hope for healthier cognitive futures. New research shows that while HIV can reach the brain within two weeks of infection, prompt treatment stops damage before it starts.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
A major clinical trial shows magnetic seizure therapy treats severe depression as effectively as electroconvulsive therapy, but with far fewer memory problems. This breakthrough could help thousands who avoid current treatments due to cognitive side effects.
Northwestern University researchers discovered a biomarker that could finally treat the cognitive symptoms of schizophrenia that current medications miss. A synthetic protein tested in animal models successfully reversed brain abnormalities linked to memory and thinking problems.
Years of relentless fundraising by an Australian family living with neurofibromatosis has led to a breakthrough discovery that could transform treatment into something as simple as diet changes or probiotics. Melbourne researchers found crucial gut bacteria differences in NF1 patients, opening doors to affordable therapies for cognitive and behavioral symptoms.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
BestCare Treatment Services broke ground on Oregon's only residential treatment center designed specifically for Latino men struggling with substance use disorder. The culturally tailored facility will provide care entirely in Spanish, addressing critical language and cultural barriers that often prevent people from seeking help.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Men with spreading prostate cancer can now postpone harsh hormone therapy for over two years thanks to a targeted radiation treatment that leaves healthy tissue untouched. A quarter of patients showed no tumors after treatment.
A new high dose version of an SMA treatment just won FDA approval, offering faster results for babies and children fighting this devastating muscle disease. The breakthrough gives families a more powerful option against a condition that once had no treatment at all.
A newly approved combination therapy is giving people with hard-to-treat multiple myeloma real hope, with over 80% of patients still alive three years after treatment. The FDA greenlit the two-injection approach after seeing results that far outpaced standard treatments.
New targeted therapies and immunotherapies for lung cancer are now reaching over 60% of patients with advanced disease, a dramatic improvement in treatment access. Fifteen states have enacted laws requiring insurance coverage for biomarker testing that helps match patients to lifesaving treatments.
A Minnesota company just won FDA approval for a breakthrough prostate cancer treatment that uses steam instead of surgery. The 30-minute outpatient procedure could help 84% of newly diagnosed patients avoid invasive treatments.
Showing 20 of 6727